Call support free: +91-9555604444

hepatitis c treatment

Showing all 2 results

HEPCVIR L ( LEDIPASVIR 90MG & SOFOSBUVIR 400MG )

International name: Harvoni (Sofosbuvir + Ledipasvir)

Name of generic: HEPCVIR-L

Manufacturer: Cipla Ltd.

Dosage: 400/90 mg

Type of packaging: can 28 tablets

HEPCVIR-L – a real bestseller against HCV from CIPLA (INDIA), an inhibitor of RNA polymerase, is approved for the treatment of patients infected with hepatitis C virus 1 and 4 genotype. HEPCVIR-L is the first FDA-approved therapy for the treatment of HCV, in which no collateral is assigned to the drug COPEGUS or short interferons. HEPCVIR-L is the official generic of Harvoni and produced in India under a patent of the copyright holder that proves its full pharmaceutical bioequivalence with the original Harvoni.

During long-term clinical studies have been proved not only by the high activity of Harvoni against the virus, but also its remarkably low toxicity. The study involved more than 1650 patients with viral hepatitis C 1 genotype. The course of treatment lasted only 84 days. At the end of therapy in 1600 patients have achieved their initial aim of treatment is the absence of the virus. Side effects that occurred because of reception of Harvoni (sofosbuvir + ledipasvir) were not clearly expressed and were accompanied mainly headache and fatigue.

FOR THE TREATMENT OF HEPATITIS C YOU CAN WHATSAPP/ VIBER US – +919555604444

Or email us at info@medimpexindia.co.in

How to Buy Hepcvir L tablet from India, learn about the availability of drugs, Online price of Hepcvir L tablet in India and order delivery?

You can get answers to all your questions by submitting an inquiry on our product page.

(http://medimpexindia.com/ )

VIRSO ( SOFOSBUVIR 400MG )

DESCRIPTION :

Price of  VIRSO in Moscow is much less than that of the original Sovaldi, as it

generic is a licensed and produced by Indian pharmaceutical company Strides.

VIRSO is also possible to buy from any country , its production started  in 2015.

Sofosbuvir from India is effective only in combination with NS5A inhibitors. We have qualified selection of medicines for the entire course of treatment. Overall clinical studies have no side effects and 98% to 100% remission after the use of sofosbuvir in the treatment of:

Hepatitis C in chronic and acute infectious form;

Complex of GS and HIV infection;

Of cirrhosis and fibrosis of the liver.

VIRSO daily dose is 1 tablet (SOFOSBUVIR 400 mg), the drug

is at the same time and regardless of the meal. During treatment